Skip to main content

Table 7 hPL manufacturing

From: Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review

hPL manufacturing

N

%

Industrial (I)

9

16.07

Buffy coat (BC)

9

16.07

Platelet-rich plasma (PRP)

15

26.79

Apheresis (Aph)

11

19.64

Apheresis and/or Buffy Coat

2

3.57

Not mentioned (N.M.)

10

17.86